Premkumar Jayaraj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Premkumar Jayaraj has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Rajagopal Desikan
Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, India
5 shared publications Sampath Parthasarathy
Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, USA
2 shared publicationsSanjay Rajagopalan
Case Western Reserve University, Cleveland, USA
2 shared publications- Akella Sivaramakrishna
Vellore Institute of Technology
1 shared publication Andrei Maiseyeu
Cardiovascular Research Institute, Case Western Reserve University, School of Medicine, 10900 Euclid Ave, Cleveland, OH 44106, USA
1 shared publicationChaitanya Sarathe
206, Structural Biology Lab, Centre for Biomedical Research, School of Biosciences & Technology, Vellore Institute of Technology, Vellore, India
1 shared publication
Latest Publications
- 9 May 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (23) , 11229-11241
A promising discovery of an anti-aging chemical conjugate derived from lipoic acid and sesamol established in Drosophila melanogaster
Phytonutrients, lipoic acid and sesamol, were chemically combined to yield the medically important lipoic acid–sesamol conjugate (LSC). NMR and LC-MS/MS techniques were used to determine the chemical structure of the LSC. The electronic parameters of the LSC were identified using density functional theory (DFT) calculations and analysed to evaluate the biological properties. The male and female flies of Drosophila melanogaster (Canton-S) were treated with the purified LSC to investigate the critical in vivo biological parameters. LSC (30 μM and 60 μM) treated flies were monitored for their lifespan and survival under heat shock, cold shock, oxidative stress, and starvation stress. We could observe that lower concentrations of the LSC increased the survival of female flies up to 18% (33 days survival) and of male flies up to 15% (31 days survival) compared with control. Also, LSC treated male and female flies display longevity when exposed to heat shock, oxidative stress, and starvation stress. This is an important aspect of discovery in the area of anti-aging studies and it will open up avenues for further investigation.
- 9 May 2022
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 46 (23) , 11229-11241
A promising discovery of an anti-aging chemical conjugate derived from lipoic acid and sesamol established in Drosophila melanogaster
Phytonutrients, lipoic acid and sesamol, were chemically combined to yield the medically important lipoic acid–sesamol conjugate (LSC). NMR and LC-MS/MS techniques were used to determine the chemical structure of the LSC. The electronic parameters of the LSC were identified using density functional theory (DFT) calculations and analysed to evaluate the biological properties. The male and female flies of Drosophila melanogaster (Canton-S) were treated with the purified LSC to investigate the critical in vivo biological parameters. LSC (30 μM and 60 μM) treated flies were monitored for their lifespan and survival under heat shock, cold shock, oxidative stress, and starvation stress. We could observe that lower concentrations of the LSC increased the survival of female flies up to 18% (33 days survival) and of male flies up to 15% (31 days survival) compared with control. Also, LSC treated male and female flies display longevity when exposed to heat shock, oxidative stress, and starvation stress. This is an important aspect of discovery in the area of anti-aging studies and it will open up avenues for further investigation.
- 5 May 2020
- Published by Wiley in ChemMedChem
- Vol. 15 (13) , 1187-1199
Synthetic Guaiacol Derivatives as Promising Myeloperoxidase Inhibitors Targeting Atherosclerotic Cardiovascular Disease
Myeloperoxidase (MPO) is known to cause oxidative stress and inflammation leading to cardiovascular disease (CVD) complications. MPO‐mediated oxidation of lipoproteins leads to dysfunctional entities altering the landscape of lipoprotein functionality. The specificity of guaiacol derivatives toward preventing MPO‐mediated oxidation to limit MPO's harmful effects is unknown. Diligent in silico studies were accomplished for a portfolio of compounds with guaiacol as a building block. The compounds’ activity toward MPO inhibition was also validated. The role of these chemical entities in controlling MPO‐mediated oxidation of lipoproteins (LDL and HDL) was shown to agree with our approach of developing powerful MPO inhibitors. The mechanism of MPO inhibition was demonstrated to be reversible in nature. This study reveals that there is great potential for guaiacol derivatives as therapeutics for CVD by modulating lipid profiles, reducing atherosclerotic plaque burden, and subsequently optimizing cardiovascular functions.
- 5 May 2020
- Published by Wiley in ChemMedChem
- Vol. 15 (13) , 1187-1199
Synthetic Guaiacol Derivatives as Promising Myeloperoxidase Inhibitors Targeting Atherosclerotic Cardiovascular Disease
Myeloperoxidase (MPO) is known to cause oxidative stress and inflammation leading to cardiovascular disease (CVD) complications. MPO‐mediated oxidation of lipoproteins leads to dysfunctional entities altering the landscape of lipoprotein functionality. The specificity of guaiacol derivatives toward preventing MPO‐mediated oxidation to limit MPO's harmful effects is unknown. Diligent in silico studies were accomplished for a portfolio of compounds with guaiacol as a building block. The compounds’ activity toward MPO inhibition was also validated. The role of these chemical entities in controlling MPO‐mediated oxidation of lipoproteins (LDL and HDL) was shown to agree with our approach of developing powerful MPO inhibitors. The mechanism of MPO inhibition was demonstrated to be reversible in nature. This study reveals that there is great potential for guaiacol derivatives as therapeutics for CVD by modulating lipid profiles, reducing atherosclerotic plaque burden, and subsequently optimizing cardiovascular functions.
- 13 January 2020
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 44 (7) , 2755-2767
A pre-formulation strategy for the liposome encapsulation of new thioctic acid conjugates for enhanced chemical stability and use as an efficient drug carrier for MPO-mediated atherosclerotic CVD treatment
Lipoyl-apocynin and lipoyl-sesamol are bio-active conjugates of thioctic acid (also known as alpha-lipoic acid), synthesized using a benign chemical approach via the combination of thioctic acid and the powerful bio-phytonutrients, apocynin and sesamol, respectively. Encapsulation was performed for chemically modified thioctic acid conjugates within a liposome structure as a possible drug carrier for targeted site delivery without chemical degradation, which could be useful in myeloperoxidase (MPO) mediated atherosclerotic cardiovascular disease (CVD) treatment. A facile processing route for the thioctic acid conjugates with the complete chemical characterization and bio-encapsulation of these chemical entities in a liposome sphere was developed, and analysis to establish the encapsulation efficiency, zeta potential, vesicle size, surface morphology, and long-term sustained stability was performed. The liposome conjugates were also characterized via critical in vitro experiments. The encapsulation efficiency of the thioctic acid conjugates was found to be almost 70%. In addition, the vesicle size and zeta potential were also measured for the formulated thioctic acid conjugates. The chromatographic evaluation of the encapsulated conjugates revealed that the liposomes seem to protect the thioctic acid conjugates when incubated in simulated body fluid, preventing ester hydrolysis, thereby offering chemical stability to the thioctic acid conjugates. The liposome loaded conjugates were also determined to be potent agents for MPO mediated atherosclerotic CVD in relevant preclinical in vitro tests. This is the first report of a highly efficient and sustainable chemical method for the liposomal encapsulation of thioctic acid conjugates of apocynin and sesamol that has been substantiated using relevant in vitro assays, and it could be useful for MPO-mediated atherosclerotic CVD treatment.
- 13 January 2020
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 44 (7) , 2755-2767
A pre-formulation strategy for the liposome encapsulation of new thioctic acid conjugates for enhanced chemical stability and use as an efficient drug carrier for MPO-mediated atherosclerotic CVD treatment
Lipoyl-apocynin and lipoyl-sesamol are bio-active conjugates of thioctic acid (also known as alpha-lipoic acid), synthesized using a benign chemical approach via the combination of thioctic acid and the powerful bio-phytonutrients, apocynin and sesamol, respectively. Encapsulation was performed for chemically modified thioctic acid conjugates within a liposome structure as a possible drug carrier for targeted site delivery without chemical degradation, which could be useful in myeloperoxidase (MPO) mediated atherosclerotic cardiovascular disease (CVD) treatment. A facile processing route for the thioctic acid conjugates with the complete chemical characterization and bio-encapsulation of these chemical entities in a liposome sphere was developed, and analysis to establish the encapsulation efficiency, zeta potential, vesicle size, surface morphology, and long-term sustained stability was performed. The liposome conjugates were also characterized via critical in vitro experiments. The encapsulation efficiency of the thioctic acid conjugates was found to be almost 70%. In addition, the vesicle size and zeta potential were also measured for the formulated thioctic acid conjugates. The chromatographic evaluation of the encapsulated conjugates revealed that the liposomes seem to protect the thioctic acid conjugates when incubated in simulated body fluid, preventing ester hydrolysis, thereby offering chemical stability to the thioctic acid conjugates. The liposome loaded conjugates were also determined to be potent agents for MPO mediated atherosclerotic CVD in relevant preclinical in vitro tests. This is the first report of a highly efficient and sustainable chemical method for the liposomal encapsulation of thioctic acid conjugates of apocynin and sesamol that has been substantiated using relevant in vitro assays, and it could be useful for MPO-mediated atherosclerotic CVD treatment.
- 6 January 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (2) , 1198-1210
Sesamol: a powerful functional food ingredient from sesame oil for cardioprotection
Phytophenols are important bioactive food based chemical entities, largely present in several natural sources. Among them, sesamol is one of the key natural phenols found in sesame seeds, Piper cubeba etc. Several studies have reported that sesame oil is a potent cardioprotective functional food. Papers on the utility of sesamol in sesame oil (the chemical name of sesamol is methylenedioxyphenol, MDP) have appeared in the literature, though there is no single concise review on the usefulness of sesamol in sesame oil in CVD in the literature. Cardiovascular disease (CVD) is the most challenging health problem encountered by the global population. There has been increasing interest in the growth of effective cardiovascular therapeutics, specifically of natural origin. Among various natural sources of chemicals, phytochemicals are micronutrients and bio-compatible scaffolds having an extraordinary efficacy at multiple disease targets with minimal or no adverse effect. This review offers a perspective on the existing literature on functional ingredients in sesame oil with particular focus on sesamol and its derivatives having nutritional and cardioprotective properties. This is demonstrated to have shown a specifically modulating oxidative enzyme myeloperoxidase (MPO) and other proteins which are detrimental to human well-being. The molecular mechanism of cardioprotection by this food ingredient is primarily attributed to the methylenedioxy group present in the sesamol component.
- 6 January 2020
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 11 (2) , 1198-1210
Sesamol: a powerful functional food ingredient from sesame oil for cardioprotection
Phytophenols are important bioactive food based chemical entities, largely present in several natural sources. Among them, sesamol is one of the key natural phenols found in sesame seeds, Piper cubeba etc. Several studies have reported that sesame oil is a potent cardioprotective functional food. Papers on the utility of sesamol in sesame oil (the chemical name of sesamol is methylenedioxyphenol, MDP) have appeared in the literature, though there is no single concise review on the usefulness of sesamol in sesame oil in CVD in the literature. Cardiovascular disease (CVD) is the most challenging health problem encountered by the global population. There has been increasing interest in the growth of effective cardiovascular therapeutics, specifically of natural origin. Among various natural sources of chemicals, phytochemicals are micronutrients and bio-compatible scaffolds having an extraordinary efficacy at multiple disease targets with minimal or no adverse effect. This review offers a perspective on the existing literature on functional ingredients in sesame oil with particular focus on sesamol and its derivatives having nutritional and cardioprotective properties. This is demonstrated to have shown a specifically modulating oxidative enzyme myeloperoxidase (MPO) and other proteins which are detrimental to human well-being. The molecular mechanism of cardioprotection by this food ingredient is primarily attributed to the methylenedioxy group present in the sesamol component.
- 26 November 2019
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 12 (2) , 95-110
Methoxyphenol Derivatives as Reversible Inhibitors of Myeloperoxidase as Potential Antiatherosclerotic Agents
Aim: To evaluate new chemical entities, based on ferulic acid scaffolds, as reversible myeloperoxidase inhibitors (MPOI). Methodology & results: In silico docking studies are performed with MPO pro...
- 26 November 2019
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 12 (2) , 95-110
Methoxyphenol Derivatives as Reversible Inhibitors of Myeloperoxidase as Potential Antiatherosclerotic Agents
Aim: To evaluate new chemical entities, based on ferulic acid scaffolds, as reversible myeloperoxidase inhibitors (MPOI). Methodology & results: In silico docking studies are performed with MPO pro...